drugset

drugset / Trial / NCT02995239

A Study to Compare the Pharmacokinetic Characteristics of CJ-12420

NCT02995239 ↗

Phase 1 Completed 12 enrolled HK inno.N Corporation

RandomizedCrossoverOpen-labelTreatment

Summary

To compare the pharmacokinetics after administration of different formulation of CJ-12420

Timeline

Start: 2015-04
Primary completion: 2015-04
Completion: 2015-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Tegoprazan	Other / unclassified	—	—

Indications